company background image
OBI

Ondine Biomedical AIM:OBI Stock Report

Last Price

UK£0.25

Market Cap

UK£48.6m

7D

1.0%

1Y

n/a

Updated

02 Dec, 2022

Data

Company Financials +
OBI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health5/6
Dividends0/6

OBI Stock Overview

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally.

Ondine Biomedical Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Ondine Biomedical
Historical stock prices
Current Share PriceUK£0.25
52 Week HighUK£0.60
52 Week LowUK£0.23
Beta0
1 Month Change1.01%
3 Month Change-35.07%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-56.90%

Recent News & Updates

Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Sep 28
Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Recent updates

Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Sep 28
Is Ondine Biomedical (LON:OBI) In A Good Position To Invest In Growth?

Shareholder Returns

OBIGB Medical EquipmentGB Market
7D1.0%-0.7%1.0%
1Yn/a-11.2%-6.0%

Return vs Industry: Insufficient data to determine how OBI performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how OBI performed against the UK Market.

Price Volatility

Is OBI's price volatile compared to industry and market?
OBI volatility
OBI Average Weekly Movement6.6%
Medical Equipment Industry Average Movement6.4%
Market Average Movement5.8%
10% most volatile stocks in GB Market11.1%
10% least volatile stocks in GB Market2.8%

Stable Share Price: OBI is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: OBI's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996n/aCarolyn Crosshttps://www.ondinebio.com

Ondine Biomedical Inc., a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens. The company’s lead product is Steriwave, a photodisinfection based medical device that eliminates harmful nasal pathogens, which leads to healthcare-associated infections.

Ondine Biomedical Inc. Fundamentals Summary

How do Ondine Biomedical's earnings and revenue compare to its market cap?
OBI fundamental statistics
Market CapUK£48.65m
Earnings (TTM)-UK£32.77m
Revenue (TTM)UK£518.88k

93.9x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
OBI income statement (TTM)
RevenueCA$856.00k
Cost of RevenueCA$463.00k
Gross ProfitCA$393.00k
Other ExpensesCA$54.45m
Earnings-CA$54.05m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.28
Gross Margin45.91%
Net Profit Margin-6,314.72%
Debt/Equity Ratio2.2%

How did OBI perform over the long term?

See historical performance and comparison